FGEMX | GABTX | FGEMX / GABTX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 6 years | 31 years | - |
Gain YTD | 27.713 | 22.859 | 121% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | 250 | - |
Net Assets | 1.71B | 66.4M | 2,578% |
Annual Yield % from dividends | 0.00 | 0.30 | - |
Returns for 1 year | 28.13 | 23.59 | 119% |
Returns for 3 years | 23.42 | 5.40 | 433% |
Returns for 5 years | 70.34 | 20.78 | 338% |
Returns for 10 years | N/A | 4.52 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYOAX | 52.14 | 0.60 | +1.16% |
Rydex Biotechnology H | |||
IVOAX | 18.21 | 0.20 | +1.11% |
Delaware Ivy Mid Cap Income Opps A | |||
GSDPX | 47.44 | 0.48 | +1.02% |
Goldman Sachs US Tax-Managed Eq P | |||
GRHIX | 12.25 | 0.03 | +0.25% |
Goehring & Rozencwajg Resources Instl | |||
VEMIX | 28.06 | -0.16 | -0.56% |
Vanguard Emerging Mkts Stock Idx Instl |